All News

Three bills to allow access to medical cannabis by veterans were removed from a House committee hearing.

Two new bills creating significant legislative movement put cannabis on the road to legalization

The FDA reminds CBD makers that CBD-infused edible products are still illegal, and calls for stakeholder input to begin regulation process

Canadian MS Society Invests $1.5 Million in Cannabis Research

Hawaii to allow visiting medical cannabis patients to get temporary medical cannabis card

In honor of National Women’s Month, Josh Crossney highlights some of the amazing women that will be speaking at the first Cannabis Science Conference East show.

Arcadia Biosciences, Inc. (Davis, California), an agricultural food ingredient company that is known for leveraging advanced, proprietary breeding techniques to improve the quality and nutritional content of wheat and soybeans, announced that they will apply their expertise cannabis.

We took a look at our most read articles from 2018; here are the top 8. 

The next step in the lawsuit against the Drug Enforcement Administration (DEA) and Department of Justice (DOJ) was heard this week at the United States Court of Appeals for the Second Circuit.

The New Zealand government passed a law on December 11, 2018, that will establish a regulated medical cannabis scheme within one year.

Jeff Zorn, the CEO and Owner of Cannabis Training University, discusses the different courses they offer, what sets them apart from other cannabis training facilities, and more.

Analytical Testing Lab Supplier Profiles from Pixis Labs and SPEX CertiPrep.

Cannabis Science and Technology is pleased to announce the launch of its editorial advisory board. 

The University of Connecticut (UConn, Storrs, Connecticut) announced plans to offer a class on cannabis horticulture through the Department of Plant Science and Landscape Architecture.

According to a recent New York Times article, doctors in the United Kingdom will be allowed to write prescriptions for medical cannabis as of November 1, 2018.

Front Range Biosciences (FRB), a leading agricultural biotech company specializing in tissue culture propagation of high value crops, announced in a press release on October 4, 2018 (1), that it has completed a $10 million Series A round of financing for cannabis research.

According to a report from CNBC.com (1), the U.S. Drug Enforcement Administration (DEA) has rescheduled GW Pharmaceuticals’ cannabidiol (CBD)-based drug, Epidiolex, to schedule V.

Highlights from the 2018 Cannabis Science Conference